DCI Indonesia Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? DCI Indonesia Tbk trades at Rp198,675 (market cap 473.71T, 1K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: DCI Indonesia Tbk is far larger — about 1524.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 1K). Which is the better fit depends on your goals.
| DCII | DGNS | |
|---|---|---|
Market Cap | 473.71T | 310.75B |
Volume | 1K | 963.6K |
Lot | 10 | 9.64K |
Turnover | 194.12M | 217.67M |
Average Price | 194,120 | 225.89 |
Value | 194.12M | 217.67M |
Indicative Equilibrium Price | 199,000 | 226 |
Indicative Equilibrium Volume | 1 | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Read more on DCII →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →